Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menorrhagia treatment Phase III trial completed:

This article was originally published in Clinica

Executive Summary

BEI Medical Systems has finished treating all patients involved in a US Phase III trial of its Hydro ThermAblator system for the treatment of excessive uterine bleeding, or menorrhagia. The 276-patient trial compared the safety and efficacy of the system with roller ball ablation, one of the current treatments for the condition. The Teterboro, New Jersey-based company, which plans to follow the patients for a year before filing a pre-market approval application with the FDA, will submit a six-month, interim patient follow-up analysis to the agency during the first quarter of 2000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079242

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel